National Live Broadcast Grand Rounds
CITY OF HOPE: State of the Art of Cancer Therapeutics: Focus on Chronic Lymphocytic Leukemia
Activity Information:
Day: Tuesday, March 19, 2019
Time: 12:00 pm-1:00 pm PST
AMA PRA Category 1 Credit™ Issued: 1.0
Moderator/Presenter(s):
Tanya Siddiqi, MD
Associate Professor
Department of Hematology and Hematopoietic Cell Transplantation
City of Hope
Associate Professor
Department of Hematology and Hematopoietic Cell Transplantation
City of Hope
Objectives:
• Determine optimal therapy/treatment for patients who have chronic lymphocytic leukemia based on the latest clinical data.
• Integrate and personalize new treatment options for chronic lymphocytic leukemia into clinical practice based on the latest clinical trial data, evidence and recommendations.
• Integrate and personalize new treatment options for chronic lymphocytic leukemia into clinical practice based on the latest clinical trial data, evidence and recommendations.
Educational Format:
This activity will be didactic with a Q&A period. This activity will be evaluated by each participant at the conclusion of the lecture.
Target Audience:
Target Audience:
This activity has been designed to address the educational needs of community and institution-based medical oncologists, hematologists, surgical oncologists, interventional radiologists, pathologists, PAs, nurse practitioners, oncology nurses, pharmacists, and other healthcare providers involved in the management of patients with cancer.
Provider Statement:
This activity is provided by City of Hope in collaboration with Paradigm Medical Communications, LLC, as an educational partner.
Accreditation Statement:
City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation:
City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education:
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education:
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Allied Health Care Professionals:
Registered nurses may report up to 1.0 credit hour toward the continuing education requirement for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 CreditTM may be noted on the license renewal application in lieu of a BRN provider number. The National Commission on Certification of Physician Assistants states that AMA PRA Category 1 CreditTM accredited courses are acceptable for continuing medical education requirements for recertification.
To receive a CME certificate of participation for this activity, participants must:
This activity is supported by educational grants from AbbVie, Inc.; Genentech, Inc.; Merck & Co., Inc.; Pharmacyclics, Inc.; and Takeda Oncology.
To receive a CME certificate of participation for this activity, participants must:
• Create an individual registration profile
• Individually sign in to the Zoom link using your Full Name and email as it appears on your registration
• View the webcast in its entirety
• After the meeting you will also receive an email with instructions to log in, complete, and submit your online posttest and evaluation. You must claim credit within 7 days of the live stream.
Please note that the last day to claim credit is Tuesday, March 26th.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation
If you would like to view this program in a group, please contact Jason Patterson at jpatterson@paradigmmc.com or by phone at 845-398-5944 for further instructions
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.Please note that the last day to claim credit is Tuesday, March 26th.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation
If you would like to view this program in a group, please contact Jason Patterson at jpatterson@paradigmmc.com or by phone at 845-398-5944 for further instructions
This activity is supported by educational grants from AbbVie, Inc.; Genentech, Inc.; Merck & Co., Inc.; Pharmacyclics, Inc.; and Takeda Oncology.
Disclosure:
As an organization accredited by the ACCME, City of Hope requires everyone who is in a position to control the content of an education activity to disclose prior to the activity all relevant financial relationships with any commercial interest. All disclosed relevant financial relationships will have been resolved prior to the commencement of the activity. We further require that prior to the activity faculty/presenters have disclosed their intention to discuss any off-label and/or investigational (not yet approved for any purpose) use of pharmaceuticals or medical devices.
Moderator/Presenter: Dr. Tanya Siddiqi has indicated that she is a Consultant for AstraZeneca, BeiGene, Ltd., Juno Therapeutics, Inc. and Pharmacyclics, Inc.; On the Speakers Bureau for AstraZeneca, Janssen Pharmaceuticals, Inc., Pharmacyclics, Inc. and Seattle Genetics.
Reviewer/Steering Committee: Dr. Daneng Li has indicated that he does not have any relevant disclosures.
Reviewer/Steering Committee: Dr. Daneng Li has indicated that he does not have any relevant disclosures.
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.
Registration:
To register for this complimentary meeting, please click Continue below or call toll-free: (877) 252-5100, ext. 1.